COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 1476: Articles 14751-14760  | Next

Assessing the Impact of Mask Usage on COVID-19 Transmission Using a Computer Simulation
Lacson, R., Veldkamp, P., Zapanta, C.
10.1101/2021.06.08.21258593 — Posted: 2021-06-09
Depressive and anxiety symptoms and COVID-19-related factors among men and women in Nigeria
Oginni, O. A., Oloniniyi, I. O., Ibigbami, O., Ugo, V., Amiola, A., Ogunbajo, A., Esan, O., Adelola, A., Daropale, O., Ebuka, M., Mapayi, B.
10.1101/2021.06.09.21258609 — Posted: 2021-06-09
Functional dependence of COVID-19 growth rate on lockdown conditions and rate of vaccination.
Mairanowski, F., Below, D.
10.1101/2021.06.06.21258425 — Posted: 2021-06-09
COVID-19 infections in day care centres in Germany: Social and organizational determinants of infections in children and staff in the second and third wave of the pandemic
Neuberger, F., Grgic, M., Diefenbacher, S., Spensberger, F., Lehfeld, A.-S., Buchholz, U., Haas, W., Kalicki, B., Kuger, S.
10.1101/2021.06.07.21257958 — Posted: 2021-06-09
High throughput sequencing based detection of SARS-CoV-2 prevailing in wastewater of Pune, West India
Dharmadhikari, T., Rajput, V., Yadav, R., Boargaonkar, R., Panse, D., Kamble, S., Dastager, S., dharne, m.
10.1101/2021.06.08.21258563 — Posted: 2021-06-09
Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial
Fisher, B. A., Veenith, T., Slade, D., Gaskell, C., Rowland, M., Whitehouse, T., Scriven, J., Parekh, D., Balasubramaniam, M., Cooke, G., Morley, N., Gabriel, Z., Wise, M., Porter, J., McShane, H., Ho, L.-P., Newsome, P., Rowe, A., Sharpe, R., Thickett, D. R., Bion, J., Gates, S., Richards, D., Kearns, P.
10.1101/2021.06.02.21258204 — Posted: 2021-06-09 Discussion: Onsite
CHA2DS2-VASc score on admission to predict mortality in COVID-19 patients: A meta-analysis
Sarkar, P. G., Kumar, A., Bandyopadhyay, D.
10.1101/2021.06.07.21258402 — Posted: 2021-06-09
Development of low-cost serological immunoassay to detect antiviral antibodies to Sars-Cov-2 Spike protein
Peroni, L., Toscaro, J., Canateli, C., Lima, G., Pagliarone, a., Cardoso, E., Viana, R., Bassani, J., Lin-Wang, H., Abboud, C. S., Gun, C., Franchini, K., Bajgelman, M. C.
10.1101/2021.06.07.21258114 — Posted: 2021-06-09
A novel RT-LAMP workflow for rapid salivary diagnostics of COVID-19 and effects of age, gender and time from symptom onset
Kobayashi, G. S., Brito, L. A., Moreira, D. D. P., Suzuki, A. M., Hsia, G. S. P., Pimentel, L. F., Barreto de Paiva, A. P., Dias, C. R., Lourenco, N. C. V., Oliveira, B. A., Manuli, E. R., Corral, M. A., Cavacana, N., Neto, M. M., Sales, M. M., Dell' Aquila, L. P., Filho, A. R., Parrillo, E. F., Mendes-Correa, M. C., Sabino, E. C., Costa, S. F., Leal, F. E., Sgro, G. G., Farah, C. S., Zatz, M., Passos-Bueno, M. R.
10.1101/2021.06.07.21258288 — Posted: 2021-06-09
Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including P.1 and B.1.1.7 variants: a test-negative design in adults 70 years and older in British Columbia, Canada
Skowronski, D. M., Setayeshgar, S., Zou, M., Prystajecky, N., Tyson, J. R., Galanis, E., Naus, M., Patrick, D. M., Sbihi, H., El Adam, S., Henry, B., Hoang, L. M. N., Sadarangani, M., Jassem, A. N., Krajden, M.
10.1101/2021.06.07.21258332 — Posted: 2021-06-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).